Showing results (1-10 of 385) with videos related to
Sort By:
Pageof 39
Current Opinion in Pharmacology|March 17, 2004
Mutant genes responsible for Parkinson's diseaseWeidong Le, Stanley H AppelJournal of Neurochemistry|September 3, 2003
Role of nitric oxide in rotenone-induced nigro-striatal injuryYi He, Syed Z Imam, Zaojun Dong, et al.The Journal of Clinical Investigation|December 24, 2008
CD4+ T cells mediate cytotoxicity in neurodegenerative diseasesStanley H AppelAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 6, 2017
Introduction to supplement: the current status of treatment for ALSRobert G Miller, Stanley H AppelJournal of Neuroimmunology|September 27, 2003
Serum anti-Fas antibody levels in amyotrophic lateral sclerosisIhsan S Sengun, Stanley H AppelThe Lancet. Neurology|January 22, 2019
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapiesDavid R Beers, Stanley H AppelJournal of Neuropathology and Experimental Neurology|September 30, 2004
Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanismWeihua Zhao, Wenjie Xie, Weidong Le, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 25, 2013
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosisWeihua Zhao, David R Beers, Stanley H AppelJournal of Neurology|June 15, 2006
Amyotrophic lateral sclerosis: early predictors of prolonged survivalAdam Czaplinski, Albert A Yen, Stanley H AppelExperimental Neurology|October 3, 2002
Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigraYi He, Wei-Dong Le, Stanley H AppelPageof 39